BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gerstung M, Jolly C, Leshchiner I, et al. (2023) Author Correction: The evolutionary history of 2,658 cancers. Nature |
Cheasley D, Nigam A, Zethoven M, et al. (2020) Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities. The Journal of Pathology |
Hunter SM, Dall GV, Doyle MA, et al. (2020) Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours. Bmc Research Notes. 13: 349 |
Martins FC, Couturier DL, Paterson A, et al. (2020) Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer |
Song H, Dicks EM, Tyrer J, et al. (2020) Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer. Journal of Medical Genetics |
Millstein J, Budden T, Goode EL, et al. (2020) Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology |
Gerstung M, Jolly C, Leshchiner I, et al. (2020) The evolutionary history of 2,658 cancers. Nature. 578: 122-128 |
Mileshkin LR, Posner A, Pattison A, et al. (2020) Identifying biomarkers to guide immunotherapy treatment of cancer of unknown primary. Journal of Clinical Oncology. 38 |
Garsed D, Pandey A, Fereday S, et al. (2020) Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer Clinical Cancer Research. 26 |
Mileshkin LR, Sivakumaran T, Etemadmoghadam D, et al. (2019) Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years. Journal of Clinical Oncology. 37: 3072-3072 |